Sign in
4

Changes in Ownership

Travere Therapeutics, Inc. Filed Acc 0001415889-25-002004

SVP, GC & CORPORATE SECRETARY sold 2,437 shares at $19.46 ($47,424)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

REED ELIZABETH E · SVP, GC & CORPORATE SECRETARY

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-01-22 Sale : show line 1 in the form 10b5-1 −2,437 $19.46 $47,424 76,933 D
Open-market sales · 2,437 sh · avg $19.46 · $47,424
Loading xslF345X05/form4-01242025_010150.xml…